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Ventricular tachycardiaIntroduction: Remotemagnetic navigation (RMN)-guided catheter ablation (CA) is a feasible treatment option for
patients presenting with ischemic ventricular tachycardia (VT). Catheter-tissue contact feedback, enhances le-
sion formation and may consequently improve CA outcomes. Until recently, contact feedback was unavailable
for RMN-guided CA. The novel e-Contact Module (ECM) was developed to continuously monitor and ensure
catheter-tissue contact during RMN-guided CA.
Objective:The present study aims to evaluate the effect of ECM implementation on acute and long-termoutcomes
in RMN-guided ischemic VT ablation.
Method: This retrospective, two-center study included consecutive ischemic VT patients undergoing RMN-
guided CA from2010 to 2017. Baseline clinical data, procedural data, including radiation times, and acute success
rates were compared between CA procedures performed with ECM (ECM+) and without ECM (ECM−). One-
year VT-free survival was analyzed using Cox-proportional hazards models, adjusting for potential confounders:
age, left ventricular function, VT inducibility at baseline and substrate based ablation strategy.
Results: The current study included 145 patients (ECM+ N= 25, ECM− N= 120). Significantly lower fluoros-
copy times were observed in the ECM+ group (9.5 (IQR 5.3–13.5) versus 12.5 min (IQR 8.0–18.0), P = 0.025).
Non-inducibility of the clinical VT at the end of procedurewas observed in 92% ECM+versus 72% ECM− patients
(P = 0.19). ECM guidance was associated with significantly lower VT-recurrence rates during 1-year follow-up
(16% ECM+ versus 40% ECM−; multivariable HR 0.29, 95%–CI 0.10–0.69, P = 0.021, reference group: ECM−).
Conclusion: Contact feedback by the ECM further decreases fluoroscopy exposure and improves VT-free survival
in RMN-guided ischemic VT ablation.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Catheter ablation (CA) is an important treatment option for patients
with ischemic heart disease presenting with ventricular tachycardia
(VT) [1,2]. CA is reported to decrease the likelihood of subsequent ICD
shocks, prolongs the time to VT recurrence and decreases VT burden
in patients diagnosed with ischemic VT [3–5]. Several CA techniquesss index; CA, catheter ablation;
e-Contact Module; EF, ejection
gy study; ICD, implantable
ft ventricle; MAN, manual; PCI,
lectrical stimulation; PVC, pre-
mote magnetic navigation; RV,
nt of Cardiology, Erasmus MC,
rok).
eliability and freedom from bias
. This is an open access article under
endriks, S.-C. Yap, et al., Conta
Journal of Cardiology, https:/are currently available for ischemic VT ablation. Some studies reported
superiority of remote magnetic navigation (RMN) over manual guided
VT ablation, exhibiting lower procedure and fluoroscopy times, higher
acute success rates, lower VT recurrence rates and less adverse events
[6–8].
CA techniques are rapidly evolving and there is a continuous search
for novel technologies to improve long-term success and reduce com-
plication rates [2]. As the quality of contact between the catheter tip
and themyocardial tissue is believed to be of vital importance for lesion
formation [9], there has been a focus on the development of technolo-
gies providing contact feedback. Contact force (CF) sensing catheters
appeared to be beneficial in manual guided atrial fibrillation ablation
[10]. However, in an observational study of VT ablations, the use of CF
sensing catheters was still inferior to RMN-guided CA with respect to
procedural outcome, long-term outcomes and safety [7]. A possible ex-
planation for the lack of benefit of CF sensing catheters inmanual VT ab-
lation is the loss of tissue contact during ventricular contraction which
can be maintained with RMN. In RMN-guided CA, contact feedbackthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Module (ECM). The present study aims to evaluate the effect of the
ECM on RMN-guided ischemic VT ablation outcomes. Our primary hy-
pothesis is that use of the ECM benefits lesion formation, resulting in
lower VT recurrence.2. Methods
2.1. Study design
This study is a retrospective, two-center study investigating ische-
mic VT ablation procedures performed with RMN. Index procedures
performed with the ECM (ECM+) were compared with index proce-
dures performedwithout ECM (ECM−). Primary endpointwas the free-
dom of VT recurrence during 12-months of follow-up (FU). We also
analyzed the following secondary endpoints: procedural parameters
(including radiation times), acute procedure success, complication
rates, the redo procedure rates and all-cause mortality at 12-months
of follow-up (FU). Additionally, the ICD therapy burden during the
12 months anticipating and the 12 months following the index proce-
dure were evaluated, as well as the proportion of ECM guided applica-
tions applied in optimal or suboptimal contact. The local ethical
committees approved data collection (MEC-2018-1114 and WO
15.142). The study protocol conforms to the ethical guidelines of the
1975 Declaration of Helsinki. Procedural informed consent was ob-
tained fromall thepatients prior to the electrophysiological study (EPS).2.2. Study population
All consecutive patients undergoing the first RMN-guided CA proce-
dure for VT with an ischemic substrate in one of the two participating
centers between January 2010 and December 2017 were included in
this study. Patients with VTs caused by a non-ischemic cardiomyopathy
were not eligible for inclusion. Participating centerswere theOnze Lieve
Vrouwe Gasthuis (OLVG, Amsterdam, the Netherlands) and the Eras-
mus Medical Center (Erasmus MC, Rotterdam, the Netherlands). Pa-
tients were eligible for VT ablation based on the most recent
guidelines and recommendations at the time of procedure [1,2]. Be-
cause of the long inclusion time, additional sub-analysis of the more re-
cently performed procedures only was performed (i.e. all procedures
performed from April 2016 to December 2017).2.3. Definitions
Index procedures were defined as the first RMN-guided VT ablation
procedure performed in a patient in one of the participating centers
within thementioned time frame. All repeat VT ablation procedures fol-
lowing the index procedure were considered redo procedures. Acute
procedure success was defined as non-inducibility of the clinical VT at
the end of procedure. Recurrence of VT was regarded when a patient
had a recurrence of a sustained VT, or VT treated with implantable
cardioverter defibrillator (ICD) therapy (either anti-tachy pacing
(ATP) or shock). Total procedure time was defined as the time from
first puncture until the removal of catheters. Mapping timewas defined
as the time from start mapping (first point taken) until completion (last
point taken), whereas ablation time was defined as time from first ap-
plication until last application.Minor complicationswere pericardial ef-
fusion not requiring intervention and access site complications. Major
complications were cardiac tamponade, hemorrhagic shock, stroke
and procedure-related death. Chronic kidney disease was considered
when a patient had an estimated Glomerular Filtration Rate (eGFR)
using the CKD-EPI formula of 59 ml/min/1.73 m2 or lower (i.e. chronic
kidney disease (CKD) stage IIIa or higher).Please cite this article as: A.M.E. Noten, A.A. Hendriks, S.-C. Yap, et al., Conta
guided ischemic ventricular ..., International Journal of Cardiology, https:/2.4. Data collection
Baseline demographic and clinical characteristics were collected
from the institutional electronic patient dossiers (HiX version 6.1
(ChipSoft BV, Amsterdam, NL) or Epic Hyperspace 2017 (Epic Systems
Corporation, Verona, WI, USA)). Procedural data was derived both
from the electronical medical files, as well as from the procedural log
files recorded with the EP-workmate (St. Jude Medical Inc., St. Paul,
MN, USA), the Niobe II or Niobe ES Magnetic Navigation System
(Stereotaxis Inc., St. Louis, MO, US) and the Odyssey Cinema system
(Stereotaxis Inc., St. Louis, MO, USA). All patient information was de-
identified.
2.5. Procedural protocol
All CAprocedureswere performed in accordancewith institutionally
approved localmedical treatment protocols of theOLVG and EMC. Abla-
tion was performed targeting VTs induced by programmed electrical
stimulation (PES) and/or modifying the electrical substrate. The left
ventricle (LV) was accessed through a transaortic or transseptal ap-
proach based on the operator's preference. In all patients, electroanato-
mic maps were obtained while patients were in sinus rhythm with the
Carto 3Dmapping system as standard of care (CARTO 3 (BiosenseWeb-
ster Inc., Diamond Bar, CA, USA)). Bipolar voltage criteria were used to
identify scar (b0.5 mV), scar-border zone (0.51–1.49 mV) and healthy
tissue (N1.5 mV). If not incessant, VT was induced by PES and activation
or entrainment mapping was performed if VT was hemodynamically
tolerable, to locate critical isthmuses and exit sites. The main target of
scar-related VT ablation was the critical isthmus of hemodynamically
stable sustained VT identified using conventional diagnostic criteria
(i.e. middiastolic potentials). Another target was the exit of the VT cir-
cuit identified during activation mapping or pace mapping. In the case
of hemodynamically unstable or noninducible sustained VT, substrate
ablationwas performed focused on areaswithin the scar demonstrating
fractionation or late potentials during sinus rhythm. It was up to the
operator's preference to perform substrate ablation in hemodynami-
cally stable VT as well in addition to targeting critical isthmus and exit
sites. Ablation was performed using the following radiofrequency set-
tings: right ventricle (RV): 40–45 W, 20 ml/min, max 43 °C; LV:
50–55 W, 30 ml/min, max 43 °C. PES was performed at the end of the
procedure to evaluate the effect of the applied therapy. RMN
(Stereotaxis, Inc., St. Louis, MO, USA) was used in all cases.
2.6. Follow-up
Following the index procedure, all patients were checked at the out-
patient clinic at regular intervals. Standard follow-up visits were:
6 months and 12 months after the procedure, including ICD check-up.
Voluntary follow-up patients were: 3months and 9months after proce-
dure. Some patients were seen evenmore frequently when they experi-
enced VT recurrences. Some patients had their FU at referral hospitals.
This data was also collected and included in the present study.
2.7. e-Contact Module
The ECM, a recently developed hardware and softwaremodule com-
patible with the Niobe ES RMN system, incorporates 16 types of data of
three categories to determine whether the catheter is in contact with
cardiac tissue or not. The following types of data are used to determine
whether the catheter is in (optimal) contact with cardiac tissue: 1) elec-
trical impedancemeasurements; 2) cardiac inducedmotion of the cath-
eter tip; and 3) the torque being applied by the magnetic field. To
confirm the different threshold levels of contact, qualitative assess-
ments based on observations during pre-clinical studies were made
while visually observing contact using intra-cardiac ultrasound. The
contact assessment is visualized to the user as a starburst near thect feedback improves 1-year outcomes of remotemagnetic navigation-
/doi.org/10.1016/j.ijcard.2020.05.028
3A.M.E. Noten et al. / International Journal of Cardiology xxx (xxxx) xxxcatheter tip and as a blue line on the contact tracing (Fig. 1).When there
isminimal contact, the starburst is small, whereas in optimal contact the
starburst is bolder. Without any contact, there is no starburst. The ECM
was installed in the EMC in April 2016 and in the OLVG in July 2017.
2.8. Quality of contact
As contact is established by the ECM by a mathematical algorithm,
calculated from 16 variables, as described above, this algorithm could
be used to evaluate the quality of contact of all RF applications applied
in patients included in the study. For every single RF application, its
time being applied in either optimal, suboptimal or without contact
with myocardial tissue was derived from the procedural log files re-
corded by the ECM and the Stereotaxis systems.
2.9. Statistical analysis
Normality was assessed by the Kolmogorov-Smirnov test, or when
appropriate, Shapiro-Wilk test. Mean and standard deviation (SD)
were calculated for normally distributed continuous variables. Median
and interquartile range (IQR) were computed for continuous variables
with non-normal distribution. Descriptive statistics for categorical
data were expressed in absolute numbers and percentages. Continuous
variables were compared between groups by the unpaired Student's t-
tests. For variables with non-normal distributions, the Mann-Whitney
U test was used. For comparing frequencies, the Chi-square test was
used, or, when appropriate, Fisher's exact test. Univariable and Multi-
variable Cox proportional hazardsmodels were used to examine the re-
lationship between treatment group and long-termoutcomes, adjusting
for potential confounders. In all ECM+ patients, Cox proportional haz-
ards models were also used to evaluate the relationship between the
quality of contact asmeasured by the ECMand the long-termoutcomes.
A 2-sided P-value of b0.05 was considered significant. Data were ana-
lyzed using SPSS 24.0 (SPSS Inc., Chicago, IL, USA).
3. Results
This study included 187 RMN-guided VT ablation procedures, of
which 145 were index procedures and 42 were redo proceduresFig. 1. The e-Contact Module. This figure shows the three types of output of the e-ContactModu
displayed without starburst. Middle: When the catheter is placed in contact with myocardial ti
optimal contact, a dense starburst is shown at the catheter tip.
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ECM (ECM−) and 25with ECM (ECM+) guidance. In total, the OLVG in-
cluded 91 patients (63%) and the Erasmus MC 54 patients (37%). In the
OLVG, 5 patients (6%) were treated with ECM guidance, whereas in the
Erasmus MC it was used in 20 patients (37%). In the OLVG, procedures
were performed by 2 operators in total. The first operator from this cen-
ter performed95% of procedures,whichwas comparable between study
groups. In the second center, 5 operators in total performed the proce-
dures over time. First operator performed the majority of procedures
(57%), the second operator performed 4%, the third 4%, the fourth 20%
and the fifth 15% of procedures, which were also comparable between
groups.
3.1. Demographic and baseline clinical data
Demographic and baseline clinical data are presented in Table 1. The
mean agewas 67.9±9.6 years. Themajority of patients had a poor LVEF
b30% (N = 82 (57%)). At baseline, 83 (58%) patients were on amioda-
rone therapy. In total, 136 (94%) patients had an ICD. Baseline demo-
graphic and clinical data were not significantly different between
groups, except for PCI being more frequently performed in the ECM+
group (ECM− 55% versus ECM+ 80%, P = 0.019).
Descriptive procedural parameters are also presented in Table 1. Epi-
cardial ablation was performed in 3 patients (3%). The ECMwas not ap-
plied to the epicardium in this study. In all ECM+ patients (N = 25,
100%) an ablation strategy including substrate ablationwas applied ver-
sus in 83% of the ECM− patients (P = 0.024). In the 21 patients (14%)
were no substrate ablationwasperformed, the ablation strategy focused
on elimination of critical isthmuses and/or exit sites only.
3.2. Procedural outcome
Mean total procedure timewas 200± SD 76min andwas compara-
ble between groups (P= 0.12), as is shown in Table 2. The mean appli-
cation duration was 1943 ± SD 1064 s. There was no significant
difference between groups (ECM− 1823 ± SD 1117 s versus ECM+
2119 ± SD 979 s, P = 0.29). Fluoroscopy time was significantly lower
in ECM+ patients (9.5 (IQR 5.3–13.5) minutes versus 12.5 (IQR
8.0–18.0) minutes, P = 0.025). Moreover, the ablation time wasle. Left:When the catheter is not in contact withmyocardial tissue, the ablation catheter is
ssue, a starburst appears at the tip of the ablation catheter. Right: When the catheter is in
ct feedback improves 1-year outcomes of remotemagnetic navigation-
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Fig. 2. Study population. The study population is presented in this figure. We included 145 index procedures in our study, of which 120 were performed without ECM and 25 with ECM
guidance. In total 42 redoprocedureswereperformed,whichwere all RMNguidedCAprocedures, someperformedwith and otherswithout ECMguidance. ECM=e-ContactModule. (For
interpretation of the references to color in this figure, the reader is referred to the web version of this article.)
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P = 0.028), whereas the mapping times were comparable between
groups. Non-inducibility of the clinical VT at the end of the procedure
was observed in 115 patients (79%), whereas non-inducibility of all VT
was observed in 84 patients (56%). The non-inducibility rates were
comparable between groups (P = 0.19 and P = 0.27, respectively).
3.3. Long-term outcome
At 12-months FU, VT recurrence was observed in 48 (40%) ECM−
patients, compared to 4 (16%) ECM+patients (P=0.023), as illustrated
in Table 2. Moreover, ECM− patients weremore frequently admitted to
the hospital because of VT recurrence (39 (33%) ECM− versus 3 (12%)
ECM+, P= 0.040). We observed a tendency towardsmore redo proce-
dures performed in ECM− patientswhen compared to ECM+, although
thiswas statistically not significant (30 (25%) versus 2 (8%) respectively,
P=0.06). Anti-arrhythmic drugswere stopped during FU in 22 patients
(16%), which consisted predominantly of therapy with amiodarone and
were comparable between groups. Twelve month FU data was incom-
plete in 11 patients (8%), which was comparable between groups
(ECM− 8 patients (7%) versus ECM+ 3 patients (12%), P = 0.90).
CA procedures performed with ECM guidance (ECM+)were associ-
atedwith improvedVT-free survival during the 12months of follow-up,
when compared to ECM− (multivariable HR 0.29, 95%-CI 0.10–0.69,
P = 0.021, with ECM− as the reference group) (Table 3a and Fig. 3).
Age, gender, LVEF, VT inducibility at baseline EPS and an ablation strat-
egy using substrate ablation, did not show a significant relationwith the
outcome. As a sensitivity analysis, center of procedure, medical history
of PCI, non-inducibility of clinical VT at end of procedure and non-
inducibility of all VT at end of procedure, were consecutively also
added to the univariate and multivariate models, and did not show
any significant associations with the primary outcome either (data not
shown). There was no significant difference between groups in all-Please cite this article as: A.M.E. Noten, A.A. Hendriks, S.-C. Yap, et al., Conta
guided ischemic ventricular ..., International Journal of Cardiology, https:/cause mortality (multivariable HR 1.47, 95%-CI 0.37–5.88, P = 0.59,
with ECM− as the reference group) (Table 3b and Fig. 3), or in the
redo procedure rates (multivariable HR 0.51, 95%-CI 0.11–2.33, P =
0.39, with ECM− as the reference group) (Table 3c). Age, gender,
LVEF and an ablation strategy using substrate ablation, procedure center
and medical history of PCI, did not show a significant relation with all-
cause mortality and redo procedure rate. However, VT inducibility at
baseline EPS was significantly related to a lower redo procedure rate
(multivariable HR 0.43, 95%-CI 0.12–0.97, P = 0.044, with VT non-
inducibility at baseline EPS as the reference group).
3.4. ICD therapy burden
In 120 patients who had an ICD implanted, the ICD therapy burden
in the 12months anticipating and 12months following the index proce-
dure was evaluated. In 16 patients, no pre-operative ICD datawas avail-
able, as the ICD was implanted during the same hospital admission as
the VT ablation procedure. Additionally, 9 patients did not have an ICD
at all. Post-procedurally, a significant lower proportion of ECM+ pa-
tients experienced ICD shocks, as compared to ECM− patients (4% ver-
sus 24%, P = 0.048). A median reduction of 2.0 (IQR 0.0–10.0) ATP
episodes and a median reduction of 1.0 (IQR 0.0–3.0) shock were ob-
served after the VT ablation procedure (Table 4), which were compara-
ble between groups.
3.5. Quality of contact
The quality of catheter-tissue contact during all ECM+ procedures
was calculated and analyzed. Themajority of the total application dura-
tion was applied in optimal contact (71% (IQR 42–83)). A small part of
the total application duration was applied without contact (6% (IQR
1–17)), whereas 21% (IQR 7–29) of the total application duration was
applied in suboptimal contact. There was no significant relationct feedback improves 1-year outcomes of remotemagnetic navigation-
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Table 1
Baseline demographic, clinical and procedural data.
ECM−
N = 120
ECM+
N = 25
Total
N = 145
P-value
Age (years)a 67.5 ± 9.9 69.8 ± 7.7 67.9 ± 9.6 0.27
Female 24 (20%) 3 (12%) 27 (19%) 0.35
BMI (m/kg2)b 26.9
(24.2–30.8)
26.0
(23.5–29.3)
26.4
(24.2–30.5)
0.44
Hypertension 46 (38%) 9 (36%) 55 (38%) 0.83
Diabetes 20 (17%) 6 (24%) 26 (18%) 0.39
Atrial fibrillation 40 (33%) 11 (44%) 51 (35%) 0.31
COPD 23 (19%) 5 (21%) 28 (19%) 0.85
Chronic kidney disease
(Stage ≥ IIIa)
56 (48%) 15 (60%) 71 (50%) 0.27
eGFR (ml/min/1.73 m2) 61 ± 19 60 ± 26 61 ± 20 0.85
Hemodialysis 2 (2%) 0 (0%) 2 (1%) 0.51
NYHA class I 30 (42%) 9 (45%) 39 (42%) 0.79
NYHA class II 18 (25%) 7 (35%) 25 (27%) 0.37
NYHA class III 24 (33%) 4 (20%) 28 (30%) 0.25
NYHA class IV 0 (0%) 0 (0%) 0 (0%) 1.00
Ischemic CMP 120 (100%) 25 (100%) 124 (100%) 1.00
Thrombolysis 12 (10%) 3 (12%) 15 (10%) 0.78
PCI 65 (55%) 20 (80%) 85 (59%) 0.019
CABG 37 (31%) 11 (44%) 48 (33%) 0.20
ICD 111 (93%) 25 (100%) 136 (94%) 0.16
VT storm 29 (24%) 4 (16%) 33 (23%) 0.38
LVEF
Normal (≥55%) 5 (4%) 0 (0%) 5 (3%) 0.30
Mildly reduced
(45–54%)
22 (18%) 3 (12%) 25 (17%) 0.45
Reduced (30–44%) 27 (23%) 6 (24%) 33 (23%) 0.87
Poor (b30%) 66 (55%) 16 (64%) 82 (57%) 0.41
(D)OAC 79 (66%) 18 (72%) 97 (67%) 0.55
Beta-blocker 98 (82%) 20 (80%) 118 (81%) 0.85
Ca-antagonist 5 (4%) 1 (4%) 6 (4%) 0.97
Amiodarone 66 (56%) 17 (68%) 83 (58%) 0.27
Sotalol 10 (8%) 3 (12%) 13 (9%) 0.56
Class 1a 4 (3%) 1 (4%) 5 (4%) 0.89
Class 1b 2 (2%) 2 (8%) 4 (3%) 0.08
Class 1c 0 (0%) 0 (0%) 0 (0%) 1.00
Procedural parameters
Approach
Right sided -
transvenous
3 (3%) 0 (0%) 3 (2%) 0.42
Left sided - transseptal 8 (7%) 3 (12%) 11 (8%) 0.36
Left sided - transaortic 105 (88%) 22 (88%) 127 (86%) 0.95
Both right and left
(transaortic)
4 (3%) 0 (0%) 4 (3%) 0.36
VT inducibility at baseline
EPS
106 (88%) 18 (75%) 124 (86%) 0.18
Mapping during VT 76 (63%) 15 (60%) 91 (63%) 0.75
Number of VT
morphologiesa
2.0 (1.0–3.0) 1.0 (1.0–3.0) 2.0 (1.0–3.0) 0.10
VT cycle length (msec)a 391 ± 101 398 ± 70 392 ± 97 0.81
Location of ablation
RV 7 (6%) 0 (0%) 7 (5%) 0.22
LV 117 (98%) 25 (100%) 142 (98%) 0.42
Epicardial 3 (3%) 0 (0%) 3 (2%) 0.42
Substrate modification 99 (83%) 25 (100%) 124 (86%) 0.024
BMI=bodymass index, CABG=coronary artery bypass grafting, CKD-EPI= chronic kid-
ney disease epidemiology collaboration, CMP = cardiomyopathy, COPD = chronic ob-
structive pulmonary disease, (D)OAC = (direct) oral anticoagulant, ECM = e-Contact
Module, eGFR = estimated Glomerular Filtration Rate (using the CKD-EPI formula),
ICD = implantable cardioverter defibrillator, LV = left ventricle, LVEF = left ventricular
ejection fraction, PCI= percutaneous intervention, RV= right ventricle, VT= ventricular
tachycardia.
a Mean ± SD.
b Median (IQR).
Table 2
Acute and long-term outcomes.
ECM−
N = 120
ECM+
N = 25
Total
N = 145
P-value
Acute outcomes
Total procedure time (min)a 206 ± 79 175 ± 56 200 ± 76 0.12
Total application duration
(sec)
1823
± 1117
2119
± 979
1943
± 1064
0.29
Total fluoroscopy time (min)b 12.5
(8.0–18.0)
9.5
(5.3–13.5)
11.0
(7.2–17.3)
0.025
Total mapping time (min) 47 ± 26 55 ± 24 49 ± 26 0.16
Total ablation time (min) 112 ± 60 83 ± 49 105 ± 59 0.028
Non-inducibility clinical VT 92 (77%) 23 (92%) 115 (79%) 0.19
Non-inducibility all VT 66 (55%) 19 (76%) 85 (59%) 0.15
12 month outcomes
VT recurrence 48 (40%) 4 (16%) 52 (36%) 0.023
Hospital admission for VT
recurrence
39 (33%) 3 (12%) 42 (29%) 0.040
Redo procedure 30 (25%) 2 (8%) 32 (22%) 0.06
Stop of ADD 17 (15%) 5 (21%) 22 (16%) 0.44
All-cause mortality 9 (8%) 3 (12%) 12 (8%) 0.46
ADD = anti-arrhythmic drugs, ECM= e-Contact Module, VT = ventricular tachycardia.
a Mean ± SD.
b Median (IQR).
Table 3
Cox proportional hazard models for VT recurrence, all-cause mortality and Redo proce-
dure rates.
Univariable model Multivariable model
Hazard
ratioa
95% CI P-value Hazard
ratioa
95% CI P-value
VT-recurrence
ECM guidance 0.34 0.12–0.95 0.040 0.29 0.10–0.69 0.021
Age 1.01 0.99–1.04 0.35 1.01 0.98–1.04 0.48
LVEF b45% 1.66 0.75–3.70 0.21 1.85 0.83–4.17 0.14
VT inducibility at
baseline EPS
0.62 0.30–1.27 0.19 0.53 0.25–1.14 0.10
Substrate
modification
0.80 0.39–1.64 0.55 1.02 0.49–2.17 0.95
All-cause mortality
ECM guidance 1.56 0.42–5.88 0.50 1.47 0.37–5.88 0.59
Age 1.03 0.97–1.10 0.40 1.03 0.96–1.09 0.42
LVEF b45% 0.37 0.05–2.86 0.34 2.50 0.32–20.00 0.38
VT inducibility at
baseline EPS
0.81 0.18–3.70 0.78 0.97 0.20–4.55 0.97
Substrate
modification
0.94 0.20–4.35 0.94 0.92 0.19–4.55 0.92
Redo procedure
ECM guidance 0.48 0.11–2.04 0.32 0.51 0.11–2.33 0.39
Age 0.99 0.95–1.03 0.60 0.98 0.94–1.02 0.30
LVEF b45% 1.09 0.37–3.23 0.88 1.12 0.38–3.33 0.83
VT inducibility at
baseline EPS
0.47 0.17–1.27 0.14 0.34 0.12–0.97 0.044
Substrate
modification
2.27 0.88–5.88 0.09 0.41 0.15–1.12 0.08
ECM=e-ContactModule, EPS=electrophysiology study, LVEF= left ventricular ejection
fraction, VT = ventricular tachycardia.
a Hazard ratios were calculated using the following reference groups: no ECM guidance
(ECM−), normal LVEF, VT non-inducibility at baseline EPS, no substrate modification
performed.
5A.M.E. Noten et al. / International Journal of Cardiology xxx (xxxx) xxxbetween the type of contact and the 12-month VT recurrence rates (ap-
plications applied without any contact: univariate HR 1.02, 95% CI
0.98–1.06, P = 0.407; applications applied in suboptimal contact: uni-
variate HR 0.94, 95% CI 0.86–1.04, P=0.227; applications applied in op-
timal contact: univariate HR 1.00, 95% CI 0.96–1.04, P=0.958). Figure 4
illustrates a case example showing an application applied in optimal
and suboptimal contact respectively (Fig. 4). There were no significantPlease cite this article as: A.M.E. Noten, A.A. Hendriks, S.-C. Yap, et al., Conta
guided ischemic ventricular ..., International Journal of Cardiology, https:/associations between LV approach (transaortic or transseptal) and the
measured quality of contact.
3.6. Safety data
Major and minor complication rates were not significantly different
between groups (major: 3% versus 0%, P = 0.42; minor: 8% versus 12%,
P = 0.56). Major complications were CVA (1 patient, who had post-
procedural hemianopia and dysartria which improved significantly
5 days after theprocedure), a completeAV block (1 patient,who alreadyct feedback improves 1-year outcomes of remotemagnetic navigation-
/doi.org/10.1016/j.ijcard.2020.05.028
Fig. 3. Cumulative VT free survival (A) and overall survival (B) of patients treated with e-Contact Feedback (ECM+) versus patients treated without e-Contact Feedback (ECM−). This
figure shows the survival curves of VT-recurrence and all-cause mortality, which were evaluated by Cox proportional hazards models. Panel A displays the VT-free survival during
12 months of follow-up. A significant higher VT-free survival was observed in patients treated with ECM guidance (ECM+) (multivariable HR 0.29, 95% CI 0.10–0.69, P = 0.021, for VT
recurrence with ECM− as the reference group). Panel B shows the all-cause mortality during 12 months of follow-up, as evaluated by Cox proportional hazards models. The all-cause
mortality was not significantly different between patients treated with the ECM connected (ECM+) and those treated without ECM (ECM−) (multivariable HR 1.47, 95% CI 0.37–5.88,
P=0.586, for all-causemortalitywith ECM− as the reference group). ECM=e-ContactModule, HR=hazard ratio, LVEF= left ventricular ejection fraction, VT=ventricular tachycardia.
6 A.M.E. Noten et al. / International Journal of Cardiology xxx (xxxx) xxxhad an DDD-ICD implanted) and RV tab during attempting pericardial
access. The RV tab was initially dry and therefore the procedure was
continued, however a few hours after completion of the procedure the
patient developed cardiac tamponade for which pericardiocentesis
was performed (1 patient, who recovered without sequelae). The ma-
jority of minor adverse events were access site complications.Table 4
ICD therapy burden.
ECM−
N = 95
ECM+
N = 25
Total
N = 120
P-value
12 months pre-procedure
Documented VT 95 (100%) 25 (100%) 120 (100%) 1.00
If yes, number of VT
episodesa
5.0
(2.0–15.0)
6.0
(4.0–18.0)
5.0
(3.0–14.8)
0.52
ATP performed 69 (73%) 19 (76%) 88 (73%) 0.29
If yes, number of ATP
episodes
5.0
(3.0–14.0)
6.0
(5.0–39.0)
5.0
(3.0–17.0)
0.10
Shock performed 66 (70%) 13 (52%) 79 (66%) 0.10
If yes, number of Shocks 2.0
(1.0–4.0)
2.0 (1.0–8.0) 2.0
(1.0–5.0)
0.19
12 months post-procedure
Documented VT 48 (50%) 4 (16%) 52 (43%) 0.023
If yes, number of VT
episodes
3.0
(1.0–10.5)
21.0
(5.0–99.3)
3.0
(1.0–12.5)
0.05
ATP performed 31 (33%) 4 (16%) 35 (29%) 0.22
If yes, number of ATP
episodes
3.0
(1.5–8.0)
21.0
(4.3–99.3)
3.0
(2.0–10.0)
0.39
Shock performed 23 (24%) 1 (4%) 24 (20%) 0.048
If yes, number of Shocks 2.0
(1.0–5.0)
1.0 (1.0–1.0) 2.0
(1.0–4.5)
0.09
Reduction
VT episode reduction 3.0
(1.0–10.3)
5.0
(1.5–18.0)
4.0
(1.0–11.0)
0.23
ATP episode reduction 2.0
(0.0–7.5)
5.0
(0.8–39.0)
2.0
(0.0–10.0)
0.09
Shock reduction 1.0
(0.0–3.0)
1.0 (0.0–3.5) 1.0
(0.0–3.0)
0.80
ECM= e-Contact Module, VT = ventricular tachycardia, ICD = implantable cardioverter
defibrillator, ATP = anti-tachy pacing, CA = catheter ablation.
a Median (IQR).
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The sub-analysis ofmore recently performedprocedures only (i.e. all
procedures from April 2016 onwards), showed that in this period, 34
patients were treated without ECM (ECM−) and 25 patients with
ECM guidance (ECM+) (Supplementary Material).
In this selected patient cohort, several demographic, clinical andpro-
cedural parameters differed significantly between the two groups at
baseline, including: gender, thrombolysis performed in the past, PCI
performed in the past, VT inducibility at baseline EPS, number of in-
duced VT morphologies at baseline EPS and LV approach (retrograde
aortic versus transseptal) (Table 1 – Supplementary Material).
With respect to the long-term outcomes, significantly lower 12-
month VT recurrence rates in the ECM+ group were observed. VT re-
currence was found in 38% of ECM− patients versus 16% of ECM+ pa-
tients (P = 0.042) (Table 2 – Supplementary Material). Cox
proportional hazards models of the subgroup showed that ECM guid-
ance (ECM+) was associated with improved VT-free survival during
the 12 months of follow-up, when compared to ECM− (Univariable
HR 0.29, 95%–CI 0.10–0.88, P = 0.028 and Multivariable HR 0.21, 95%–
CI 0.06–0.71, P = 0.012, with ECM− as the reference group). Age, gen-
der, LVEF, VT inducibility at baseline EPS and an ablation strategy using
substrate ablation, consistently did not show a significant association
with the outcome (Table 3 – Supplementary Material).
4. Discussion
This is the first study to assess the clinical outcome of contact feed-
back in RMN-guided CA. Our results suggest that contact feedback by
the ECM improves VT free survival in RMN-guided ischemic VT ablation.
4.1. The importance of catheter-tissue contact
Effective lesion formation is a major determinant of outcome in VT
ablation. In addition to traditional indices of power and RF duration, le-
sion continuity, catheter stability and contact have emerged as key ele-
ments influencing effective lesion formation [11]. Different contactct feedback improves 1-year outcomes of remotemagnetic navigation-
/doi.org/10.1016/j.ijcard.2020.05.028
Fig. 4. Case example. This figure is a case example of one of the patients from our cohort treated with ECM guidance. At the left end, CARTO electroanatomic maps of the left ventricle are
displayed. The electroanatomic maps are displayed more transparent, whereas previous ablation points are displayed in less-transparent yellow and orange (i.e. the “Ablation History”
feature of the Stereotaxis system). On the right, ablation parameters of the currently performed application are displayed, including temperature, power and impedance (recorded by
the Claris system). Panel A displays an application applied in suboptimal contact. The suboptimal catheter-tissue contact is shown to the user by the ECM as a small starburst at the
catheter tip. One can appreciate that during this specific application the impedance was stable. On the contrary, Panel B shows an application applied in optimal catheter-tissue contact
(visualized by a dense starburst at the catheter tip), where we observed a gradual impedance drop during ablation, which is related to improved lesion quality. (For interpretation of
the references to colour in this figure legend, the reader is referred to the web version of this article.)
7A.M.E. Noten et al. / International Journal of Cardiology xxx (xxxx) xxxmatters are of importance, including contact homogeneity across a line
of ablation, spatiotemporal dynamics of contact governed by cardiac
and respiratory motion and contact directionality [11]. Moreover, con-
tact is of critical importance in adequate three-dimensional electro-
anatomic mapping, another determinant of substrate ablation outcome
[12]. This is illustrated by when a normal region is mislabeled as low-
voltage scar due to poor tissue contact. Improved contact permits to de-
fine the areas of reduced potentials [12] and increases the sensitivity of
late potential detection [13]. The present study observed that imple-
mentation of a novel contact assessing technology during RMN-guided
ischemic VT ablation, resulted in higher VT-free survival. Consistently,
less ICD shocks and less hospital admissions for VT recurrence were ob-
served. Hypothetically, two factors are the key elements explaining how
the ECM improved ablation outcome. First of all, real-time contact feed-
back potentially improves the efficacy of VT ablation by virtue of more
accurate maps [12]; points were predominantly taken when the ECM
showed that therewas optimal catheter-tissue contact. Secondly, by op-
timizing lesion formation [11]; the RF application was only started
when the ECM showed there was optimal contact and catheter position
was continuously optimized by the operator during ablation. It would
be interesting to further investigate the ECM's exact determination of
size, definition and resolution of low-voltage areas in future studies in-
volving scar related VT.
4.2. Remote magnetic navigation versus manual guided VT ablation
Wheremanual ablation catheters are still confined to uni- or bidirec-
tional movement using pull wires [8], magnetic navigation ensures en-
hanced maneuverability of the ablation catheter that makes reach of
difficult anatomical structures possible [14,15]. Magnetic guidedPlease cite this article as: A.M.E. Noten, A.A. Hendriks, S.-C. Yap, et al., Conta
guided ischemic ventricular ..., International Journal of Cardiology, https:/ablation by itself aids to achieve more adequate lesion formation by en-
hanced catheter stability and consequently improved contact with the
myocardial wall [16,17]. This is of critical importance in cardiac regions
with greater wall motion excursion such as the ventricle. RMN facili-
tates titration of CF between the catheter and the myocardial tissue.
Most studies comparing manual with RMN-guided VT ablation, re-
ported superiority of RMN, with respect to procedure and fluoroscopy
times, acute success rates and adverse events [7,8]. Moreover, in VT ab-
lation of patients with non-structural heart disease, RMN reported sig-
nificantly lower VT recurrence rates during long-term FU [6]. The
present study reported lower procedure, fluoroscopy and mapping
times, when compared to prior studies evaluating RMN guided ablation
of scar related VT [18].Moreover, we observed even further reduction of
VT recurrence, ablation time and fluoroscopy exposure after implemen-
tation of the ECM. In our opinion this illustrates the technological ad-
vances made in RMN guided ablation over time and highlights that
the ECM was rapidly embedded in daily practice by the operating
electrophysiologists.
4.3. The e-Contact Module
CF inmanual guided CA is determined electromechanically based on
the amount of mechanical deformation or diffraction of light experi-
enced by the catheter tip [19]. In contrast to CF sensing catheters in
manual guided CA, the ECMdoes not inform on the quantity of force ap-
plied. In RMN's ECM, contact in fact is calculated by a combination of
factors including the vector of the ablation catheter, wall motion and
impedance. The ECM in RMN-guided ablation takes into account the
angle between the tip of the catheter andmyocardial surface that affects
the pattern of the systodiastolic contact. In larger scars contactct feedback improves 1-year outcomes of remotemagnetic navigation-
/doi.org/10.1016/j.ijcard.2020.05.028
8 A.M.E. Noten et al. / International Journal of Cardiology xxx (xxxx) xxxmeasurements may be less reliable, there wall motionmay be distorted
due to akinesia or dyskinesia and impedance is altered due to changes in
conduction properties. Yet, the ECM incorporates 16 variables to gauge
contact that aids to high accuracy. The results of the present study, are in
our opinion a confirmation of the accuracy of this novel feature,
assisting to the composition of accurate maps and advancing effective
lesion formation.
4.4. The quality of contact
This study also evaluated the measured quality of contact of every
single RF application. According to the ECM, we observed that 92% of
the total RF application timewas applied in contact withmyocardial tis-
sue, of which N70% was applied in optimal contact. Six percent of the
total RF application time was applied without any contact with the
myocardium. Interestingly, even though not all applications were ap-
plied in optimal contact, we observed improved outcomes. Real-time
contact feedback of the ECM, allows operators to constantly optimize
catheter position while ablating reducing cumulative application time
in suboptimal catheter position. Whether this explains the improved
12-month outcome in this study, should be verified in future studies
where the operator is blinded versus unblinded to the ECM. Moreover,
it would be interesting to investigate the effect of other parameters,
such as LV approach, on the measured quality of contact.
4.5. Limitations
The present study's retrospective nature and the lack of blinded ad-
judication might have introduced bias, although this was mitigated by
the use of objective measures. The present study included all proce-
dures performed since the implementation of ECM. As the operators
had to learn how to incorporate the ECM's feedback in their procedural
approach, this learning curvemight have negatively affected our results.
Nevertheless, we observed a significantly better long-term outcome in
procedures performed with ECM. Nowadays substrate ablation is
being performed as per standard of care in all patients, whereas in the
earlier days sometimes the procedure focused on elimination of critical
isthmus and exit sites only. Moreover, insights on substrate ablation
methodology changed over time. Possibly, it led to an improved aboli-
tion of channels [20,21] and this could have biased our results. However,
substrate ablation as potential confounder was added to the Cox pro-
portional hazard models and did not show a significant relation with
the outcomes.
5. Conclusion
Contact feedback by the ECM appears to improve 1-year outcome in
RMN-guided ischemic VT ablation, resulting in a higher 1-year VT free
survival. Moreover, implementation of the ECM significantly reduces
fluoroscopy exposure. These observations are most likely the result of
improved accuracy of mapping and advanced ablation lesion formation
due to the contact feedback provided by the ECM.
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